LXN Polyclonal Antibody

Background:
Latexin, also designated endogenous carboxypeptidase inhibitor (ECI) or tissue carboxypeptidase inhibitor (TCI), belongs to the protease inhibitor I47 family of proteins. Latexin acts as a non-competitive, reversible inhibitor for metallocarboxypeptidases (MCPs), including CPA1, CPA2 and CPA4. It is a cytoplasmic protein that is highly expressed in heart, prostate, pancreas, ovary, kidney, brain and colon. Latexin consists of two topologically equivalent subdomains that bind to MCPs with low specificity, which gives it with the flexibility to inhibit all vertebrate A/B MCPs.

Research Area: Cancer, Cell Biology, Immunology, Stem Cells, Tags and Cell Markers

Synonyms:
ECI, Endogenous carboxypeptidase inhibitor, Latexin, Latexin protein, LXN, LXN, MUM, Protein MUM, TCI, Tissue carboxypeptidase inhibitor

Immunogen: Recombinant protein of human LXN

Swissprot: Q9BS40
Gene Accession: BC005346

Calculated MW: 26 kDa

Purification Method: Affinity purification

Buffer: PBS with 0.05% sodium azide and 50% glycerol, PH7.4

Concentration: 0.2 mg/mL
Dilution: WB 1:1000-1:5000

Storage:
Store at -20°C. Avoid freeze / thaw cycles.

Alternative for product with catalog number:
sc-47090/sc-47089/sc-47087/sc-47090/sc-47089/sc-47087/sc-99035